Study Links Gene Variants and Sleep Habits to Brain Health and Alzheimer's Risk

A new study from Edith Cowan University (ECU) in Western Australia has uncovered a link between sleep habits and the future risk of Alzheimer's disease. Published in Alzheimer's & Dementia, the research indicates that variants of the aquaporin-4 (AQP4) gene, which influences brain fluid movement, interact with an individual's sleep patterns. This interaction affects brain structure and cognitive performance long before symptoms of Alzheimer's appear.

The brain's waste-clearing system is most active during sleep and helps flush out proteins associated with Alzheimer's. The study found that the effectiveness of this system depends on which AQP4 gene variant a person possesses and their sleep habits. Specifically, certain AQP4 variants were associated with faster grey matter loss in individuals who reported shorter sleep durations.

The research involved 351 older adults participating in the Australian Imaging, Biomarkers, and Lifestyle (AIBL) study. These participants, in their mid-70s, showed no diagnosed cognitive impairments but exhibited signs of amyloid buildup, a hallmark of Alzheimer's disease. Researchers tracked common variants of the AQP4 gene against participants' self-reported sleep, conducting repeated brain scans and cognitive tests.

Findings showed that for some gene variants, shorter sleep correlated with accelerated grey matter loss. For others, the speed of falling asleep was a more significant factor. Notably, longer sleep duration was not universally beneficial; for at least one variant, those who slept longer experienced a steeper decline in cognitive ability compared to shorter sleepers. Researchers caution that genetics alone do not dictate outcomes, but emphasize that sleep is a modifiable factor, suggesting potential for personalized Alzheimer's prevention strategies.